Protective effect of (-) clausenamide against neurotoxicity induced by okadaic acid and β-amyloid peptide25-35

Yaoxue Xuebao

Volumn 42, Issue 9, 2007, Pages 935-942

  Zhang, Jing ^a   Cheng, Yong ^a   Zhang, Jun Tian ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

amyloid peptide25 35; ( ) Clausenamide; Alzheimer's disease; Neuroprotective effect; Okadaic acid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); CLAUSENAMIDE; HERBACEOUS AGENT; LACTAM; LACTATE DEHYDROGENASE; LIGNAN; NEUROPROTECTIVE AGENT; OKADAIC ACID; PEPTIDE FRAGMENT;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL SURVIVAL; CHEMISTRY; CLAUSENA; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HUMAN; ISOLATION AND PURIFICATION; LEARNING; MEDICINAL PLANT; MEMORY DISORDER; METABOLISM; NERVE CELL; NEUROBLASTOMA; OVARIECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CEREBRAL CORTEX; CLAUSENA; DRUGS, CHINESE HERBAL; FEMALE; HIPPOCAMPUS; HUMANS; L-LACTATE DEHYDROGENASE; LACTAMS; LEARNING; LIGNANS; MEMORY DISORDERS; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; OKADAIC ACID; OVARIECTOMY; PEPTIDE FRAGMENTS; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 42149162262     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Selkoe DJ. The molecular pathology of Alzheimer's disease [J]. Neuron, 1991,6:487-498.
2. Tang K, Zhang JT. (-) Clausenamide improves longterm potentiation impairment and attenuates apoptosis after transient middle cerebral artery occlusion in rats [J]. Neurol Rev, 2003,25:713-717.
3. Duan WZ, Zhang JT. Inhibition of (-), (+) clausenamide to acetylcholinesterase [J]. Chin J Pharmacol Toxicol, 1998,12:16-19.
4. Paxinos G, Watson C. The rat brain in stereotaxic coordinates [M]. Australia: Academic Press, 1986:21.
5. Tanaka T, Zhong J, Iqbal K, et al. The regulation of phosphorylation of tau in SY5Y neuroblastoma cells; the role of protein phosphatases [J]. FEBS Lett, 1998,426: 248-254.
6. Alvarez G, Munoz-Montano JR, Satrustegui J, et al. Regulation of tau phosphorylation and protection against β-amyloid-induced neurodegeneration by lithium. Possible implications for Alzheimer's disease [J]. Bipolar Disord, 2002,4:153-165.
7. Gong CX, Lidsky T, Wegiel J, et al. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease [J]. J Biol Chem, 2000,275:5535-5544.
8. Chuang DM. Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative disease? [J]. Crit Rev Neurobiol, 2004,16:83-90.
9. Chuang DM, Chen RW, Chalecka-Franaszek E, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases [J]. Bipolar Disord, 2002,4: 129-136.
10. Hong M, Chen DC, Klein PS, et al. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3 [J]. J Biol Chem, 1997,272:25326-25332.
11. O' Brien WT, Harper AD, Jové F, et al. Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium [J]. J Neurosci, 2004,24:6791-6798.
12. Liu SJ, Zhang AH, Li HL, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory [J]. J Neurochem, 2003,87:1333-1344.
13. Lovestone S, Hartley CL, Pearce J, et al. Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells; the effects on the organization and stability of microtubules [J]. Neuroscience, 73: 1145-1157.
14. Phiel CJ, Wilson CA, Lee VM, et al. GSK-3α regulates production of Alzheimer ' s disease amyloid-β peptides [J]. Nature, 2003,423:435-439.
15. Alvarez G, Munoz-Montano JR, Satrustegui J, et al. Lithium protects cultured neurons against β-amyloidinduced neurodegeneration [J]. FEBS Lett, 1999,453: 260-264.
16. 25-35-induced tau hyperphosphorylation in cortical neurons [J]. Acta Pharm Sin, 2005,40:225-230.
17. Simpkins JW, Green PS, Gridley KE, et al. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer ' s disease [J]. Am J Med, 1997,103:19S-25S.
18. Goodenough S, Schäfer M, Behl C. Estrogen-induced cell signaling in a cellular model of Alzheimer's disease [J]. J Steroid Biochem Mol Biol, 2003,84:301-305.